Clinical characteristics and management of paroxysmal junctional tachycardia in the elderly  by Yangni N’Da’, O. & Brembilla-Perrot, B.
© 2008 Elsevier Masson SAS. All rights reserved.
Archives of Cardiovascular Diseases 101 (2008) 143–148
Available on www.sciencedirect.com
CLINICAL RESEARCH
Clinical characteristics and management 
of paroxysmal junctional tachycardia in the elderly
Caractéristiques cliniques et prise en charge des tachycardies
jonctionnelles paroxystiques chez le sujet âgé
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Summary
Background. — The proportion of elderly subjects is in progress. While atrial fibrillation is the
most frequent arrhythmia after the age of 70 years, other tachycardias also occur in the
elderly. 
Aims. — The aim of this study is to assess the clinical and electrophysiological characteristics
of paroxysmal junctional tachycardia (PJT) in patients older than 70 years.
Methods. — Eight hundred sixteen patients aged from 8 to 93 years have been consecutively
recruited for PJT. Among them, 141 (17%) were older than 70 years. The clinical, electro-
physiology and therapeutic data were studied.
Results. — Forty-eight men and 93 women with an age range from 70 to 93 years (mean 76±5)
were admitted for recurrent PJT. They were associated to cardiac decompensation in 10 cases,
syncope in 26 cases, acute coronary syndrome in 14 cases and unexplained acute vascular event
in 5 cases. The electro-physiological mechanism of the PJT was similar to the younger patients
with a majority of nodal reentrant tachycardia (73%). Atypical nodal tachycardias were more
frequent than in the youth (15 versus 4%). PJT ablation was indicated more frequently in elderly
patients than in younger patients (79 versus 57%), but complications (7% versus 2.5%) and
failures, especially related to atrial fibrillation induction (19% versus 5%) were more frequent
in elderly patients.
Conclusion. — Junctional tachycardias are not rare in the elderly and should not be missed. A
cautious medical treatment can be impeded by the presence of conduction troubles or
comorbidities. If this approach is not efficacious, these subjects might take benefit from
curative ablation, with still a 10% failure rate.
© 2008 Published by Elsevier Masson SAS.
Résumé
Justification. — La population âgée augmente. Si la fibrillation auriculaire (FA) est l’arythmie
la plus fréquente après 70 ans, d’autres tachycardies surviennent chez le sujet âgé. 
Objectifs. — Le but de cette étude a été d’évaluer les caractéristiques cliniques et
électrophysiologiques de sujets de plus de 70 ans ayant une tachycardie jonctionnelle paroxystique
(TJP). 
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Méthodes. — Huit cent seize patients âgés de 8 à 93 ans ont été recrutés consécutivement
pour une TJP ; 141 d’entre eux avaient au moins 70 ans (17 %). Leurs données cliniques,
électrophysiologiques et thérapeutiques ont été évaluées. 
Résultats. — Quarante-huit hommes et 93 femmes, âgés de 70 à 93 ans (moyenne 76±5) ont
été admis pour des TJP récidivantes qui avaient la particularité d’être associées à une
décompensation cardiaque dans 10 cas, une syncope dans 26 cas, un syndrome coronarien aigu
dans 14 cas, un accident vasculaire inexpliqué dans 5 cas. Le mécanisme électrophysiologique
de la TJP a été similaire à celui des sujets plus jeunes avec une majorité de tachycardies par
réentrée intranodale (73 %). Les tachycardies intranodales atypiques ont été plus fréquentes
que chez les sujets plus jeunes (15 versus 4 %). L’indication d’ablation a dû être portée plus
fréquemment que les sujets plus jeunes (79 versus 57 %) avec des complications (7 versus 2,5 %)
et des échecs plus fréquents du fait surtout de l’induction d’une fibrillation auriculaire
(19 versus 5 %).
Conclusion. — Il ne faut pas méconnaître les tachycardies jonctionnelles du sujet âgé qui ne
sont pas rares et s’expriment souvent par une autre complication. Si le traitement médical
prudent, rendu difficile par les troubles de conduction associés et les comorbidités, n’est pas
efficace, ces sujets peuvent bénéficier des procédures de traitement curatif par ablation, avec
cependant un risque d’échec de 10 %.
© 2008 Published by Elsevier Masson SAS.
Introduction
The auriculo-ventricular junction tachycardias or paroxys-
mal junctional tachycardias (PJT) use in their total or par-
tial trajectory the Tawara node and/or the His bundle down
to its bifurcation.
They are mostly paroxysmal and rarely chronic. The PJT
are mainly due to nodal reentry (typical or atypical) and
sometimes related to a latent Bundle of Kent with exclusive
retrograde conduction. Junctional tachycardias can also
complicate the evolution of a patent Wolff-Parkinson-
White, but this affection is more infrequent and is presen-
ted in another study and this as far as other more severe
tachycardias may also complicate this affection.
In the United States, 89.000 new cases are reported
yearly, and a total of 570.000 patients are affected by
paroxysmal supraventricular tachycardia. The prevalence is
estimated at 2.25/1000 subjects, but these data involve all
types of supraventricular tachycardia as a whole [1].
Classically benign in the youth, junction tachycardia is
often poorly tolerated in the elderly, because it is rapid or
unfelt but prolonged or due to an underlying cardiac
disease [2].
Despite, this condition is more known in young subjects
and infrequently reported in the elderly. Above all paroxys-
mal and sustained atrial fibrillation are reported after the
age of 70, even though PJT is not rare in the elderly.
The aim of this study is to assess the clinical and electro-
physiological characteristics and the therapeutic conse-
quences of PJT noted in the elderly.
Population and methods
Patients
The study population includes 141 patients (48 men and
93 women) aging from 70 to 93 years (mean 76±5 y) who
presented several episodes of PJT despite drug therapy.
They are selected from a series of 816 patients studied
between 1985 and 2006 for the assessment of probable or
documented tachycardia. Non-critical ECG recorded sinus
rhythm without pre-excitation. 
The diagnosis has been confirmed by ECG during tachy-
cardia showing regular tachycardia with sudden onset and
termination, with narrow QRS complexes similar to those
during sinus rhythm. They occurred spontaneously or after
being triggered during esophageal and/or intracardiac elec-
trophysiology (EP) exploration.
Methods
Electrophysiology study protocol
The electrophysiology (EP) study was performed through
esophageal exploration if the tachycardia was not docu-
mented or intra-cardiac exploration when the tachycardia
was already documented, in order to attempt ablation. The
protocol was similar for the two approaches although the
means have been different.
The esophageal auricular pacing was performed during out-
patient consultation. We used a bipolar pacing catheter (Fiab,
EIA/Sorin, Prothia SP 8). Pacing was first performed using a
standard EP pacer (Explorer 2000 Ela), connected to an
impulse amplifier (Ela medical), which can deliver 20 ms width
and 29 v amplitude pulses. In practice, 16 ms width impulses
were actually used, with mean amplitude varying from 15 to
25 v [3]. Since 3 years ago, we have used the intra-cardiac
biphasic pacer (Micropace, Bard France). This system can deli-
ver impulses of 10 ms width, and 8 to 25 mv amplitude.
The protocol, common to both intra-cardiac and esopha-
geal pacing has already been reported elsewhere [3]:.basal state: we performed increasing frequencies auri-
cular pacing up to the Wenckebach point, and then used
a programmed auricular pacing using 1 and 2 extrastimu-
lus delivered in two imposed cycles of 600 and 400 ms;.if tachycardia was not triggered: this protocol was repea-
ted after isoproterenol infusion at the dosage of 0.02 to
1 μg/mn, adjusted for heart rate, with mean heart rate
ranging from 130 to 150 bpm;
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Definitions
Once the tachycardia triggered, the esophageal or intra-car-
diac ECG was recorded. To determine the reentry site, we used
the classical EP parameters. Specifically we noted the trigge-
ring mode of the tachycardia by looking for a sudden jump of
AV delay as a sign of presence of a double nodal pathway. We
also looked for the effects of a bundle branch block on the
tachycardia cycle, and examined the P wave morphology in
leads V1 and I, and above all noted the position of the auricular
complex compared to the ventricular complex. .Junctional tachycardia (T) was attributed to atrioventri-
cular nodal reentry (AVNR) if it was started after a sud-
den jump of the AV delay, if the VA interval was below
70 ms, and if there was an AV dissociation during the epi-
sodes of tachycardia;.the tachycardia was attributed to a reentry through an
accessory pathway (AVRT) if the auricular complex fol-
lowed the ventricular one after a delay exceeding 70 ms
or if the functional right or left bundle branch block
increased the tachycardia cycle, if P wave was negative
at lead I and if the P wave at V1 lead occurred after eso-
phageal atrial activity. The VA delay was constant;.the mechanism remained undetermined if these criteria
were not noted, if during intra-cardiac exploration a
retrograde conduction through the normal or accessory
pathways occurred which was not present under the spon-
taneous tachycardia frequency even under isoproterenol
and finally if the clinical tachycardia was not induced.
Radiofrequency ablation of the reentry circuit
In case of indication of radiofrequency (RF) ablation of the
reentry circuit, this protocol also included increasing fre-
quency ventricular pacing, in order to study the retrograde
conduction.
In a second step, the RF ablation of the reentry circuit
(ablation of the slow pathway in case of nodal reentry or of
a latent accessory bundle) was performed using the “Stoc-
kert” device (Cordis, USA) with a power delivery limited at
50W and temperature limited at 65°C during 60 seconds [2].
After ablation, the initial pacing protocol is repeated
during 30 minutes after the shot, and if the tachycardia is
triggered again, the same procedure was repeated. The
procedure was stopped when no retrograde conduction
through the bundle of Kent was found or when it was impos-
sible to trigger the junctional tachycardia related to nodal
reentry. In this case, the procedure was stopped either in
case of complete ablation of the slow pathway, or when it
was only possible to induce only 1 to 3 echoes during the
programmed pacing technique.
Statistics
The results are presented by the mean and standard devia-
tion. The differences in the clinical and EP data were tested
using the Chi-2 and Student’s t-test as appropriate.
Results
Clinical characteristics
A majority of patients presented palpitation, sometimes for
years, but being more frequent and refractory to anti-
arrhythmic drugs. Three patients have experienced these
episodes for 20 years. An 88 years-old patient has presented
these episodes since the age of 20, and another patient of
73 years has experienced these episodes since the age of 4.
The tachycardias were sometimes slowed by anti-arrhyth-
mic drugs or were spontaneously slow due to underlying
conduction abnormalities.
The tachycardia could have been prolonged during seve-
ral hours and even days, turning to be ceaseless or chronic
in 8 patients. Palpitations could have been increasingly
disabling and poorly tolerated. Conversely, in some patients,
the tachycardias remained asymptomatic.
Twenty-six patients (18%) presented presyncope (n=3)
and/or syncope (n=23). During tachycardia episodes,
14 patients (10%) experienced angina, sometimes very disa-
bling. Five patients presented an unexplained stroke and
AVNRT was the only arrhythmia induced during esophageal
EP exploration. Ten patients had a heart failure episode
due to tachycardia.
Associated conditions
Heart disease was associated to the tachycardia in 35
patients (25%):.a 76 year-old female patient presented an atypical
AVNRT complicated by acute pulmonary edema, with one
episode managed with mechanical ventilation. She pre-
sented a non-obstructive hypertrophic cardiomyopathy
(HCM). Two additional cases also had HCM;.sixteen patients suffered from ischemic heart disease,
with one case complicated by dilated cardiomyopathy.
The patient had triple-vessel disease;.eight other cases had dilated cardiomyopathy, appearing as
primitive in 4 cases, following the use of anthracyclines in one
patient and related to hypertension in another case. In 2
other cases with almost permanent tachycardia due to a slow
accessory pathway and admitted for NYHA stage IV heart
failure, the left ventricular function has been normalized a
few weeks after the ablation of the accessory bundle;.three other cases presented hypertensive heart disease;.two patients had chronic pulmonary heart;.four patients presented a progressed valvular disease
(mitral regurgitation in 2 cases, mixed aortic stenosis and
regurgitation in 2 cases);.three patients had an associated blood disease and 3 other
cases had chronic respiratory failure.
Associated arrhythmias (n=59,42%)
.In 15 patients (11%) a substantial bradycardia or sinus node
dysfunction was present;.three patients had a first-degree AV block, including
three cases with RBBB and another case with left anterior
fascicular block;.five other patients had a RBBB;.three patients had a LBBB and three others presented a
left anterior fascicular block;.one patient had a pacemaker;.nineteen patients presented other types of supraventricu-
lar tachycardia (atrial fibrillation or atrial tachycardia);.one patient presented also episodes of ventricular tachy-
cardia.
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Tachycardia characteristics
The PJT was due to a typical AVNRT in 101 patients (72%), and
was related to an atypical AVNRT in 21 patients (15%). In this
latter case the interval between the QRS complex and retro-
grade atrial activity was very long and the retrograde conduc-
tion used the AV node. The PJT was due to a reentry through
a latent bundle of Kent in 11 patients (8%). We found both
typical and atypical tachycardia in 2 patients. One patient
had a typical AVNRT as well as a latent bundle of Kent.
In one patient the nature of tachycardia was difficult to
characterize: it was a “slow-slow” atypical AVNRT or a latent
right posteroseptal bundle of Kent.
In two cases the tachycardia was connected to a focal
automatic activity in the nodal area.
Other electrophsiologic data
A sinus node dysfunction was found in 13 cases.
One patient had an intra-His block and another a prolon-
ged HV interval at 75 ms.
Two patients who had a LBBB presented a traumatic and
regressive complete AV block during the manipulation of
intra-cardiac catheters.
In 27 patients (19%) an atrial fibrillation was induced,
including two with a history of stroke.
Treatment
In 29 patients PJT was controlled with low doses of beta-
blockers. 
The indication of RF ablation was decided in case of
poorly tolerated treatment or in case of recurring PJT in
112 patients. The ablation of the slow pathway or the
latent bundle of Kent was attempted in 102 and 10 cases,
respectively.
A high rate of 11 failure cases was noted due to the
failure to approach of the retrograde bundle of Kent due to
severe atherosclerotic lesions, or in case of induction of
irreducible tachycardia or atrial fibrillation in 7 cases.
Other causes of failures were the very proximal situation of
the slow pathway next to the His bundle (2 cases), the
occurrence of traumatic regressive complete AV block only
after the catheters withdrawal in one case. Small Koch
triangle was noted in 12 patients.
Seven patients presented a regressive second-degree AV
block.
Two deaths are directly related to cardiac catheteriza-
tion. The first was due to the occurrence of a huge femoral
hematoma in a female patient with Kahler disease followed
by intravascular disseminated coagulation and consecutive
cerebral hemorrhage. In the second case a cardiovascular
collapse occurred when the patient got up the day after the
procedure. She had a mild aortic stenosis. The telemetric
surveillance during death revealed no arrhythmia.
Follow-up
The follow-up period ranged from 6 months to 7 years.
Two patients presented unexplained stroke despite the
ablation of the slow pathway. Patients who experienced
stroke prior to the procedure did not present any recur-
rence but the occurrence of paroxysmal AF in two cases led
to the prescription of anticoagulants.
A PJT recurrence was noted in 10 patients with a new
ablation procedure. In 8 cases PJT was difficult to trigger in
the beginning of the procedure, with the induction of atypi-
cal tachycardia in 5 cases. In these 8 patients PJT was
finally impossible to trigger again and a block of the slow
pathway was apparently obtained for all of them, without
induction of echoes. In two other cases an accelerated
junctional rhythm (>100/min) remained inducible after iso-
proterenol infusion, while initially a more rapid junctional
tachycardia (>150/min) was induced.
Two out of 10 patients who initially had a reversible
second-degree AV block finally needed a pacemaker several
months later.
An irreducible atrial fibrillation was noted in 12 patients
after 1 month to 5 years after ablation.
Two patients deceased during follow-up: In one case sud-
den death occurred 3 months after ablation of an AVNRT.
The other case was related to cardiac decompensation due
to a rapid atrial fibrillation, 8 months after the procedure.
Conversely, the patients who experienced an acute coro-
nary syndrome or heart failure during an episode of PJT
have not been readmitted in hospital during follow-up and
remained in stages I or II of their conditions.
Comparison with subjects <70 years of age
Table 1 shows higher rates of concomitant cardiac diseases
after the age of 69. During cardiac catheterization, syncope
and risk of atrial fibrillation induction was also more fre-
quent in the older group. The indication of ablation has
been more frequent in the older patients, with a higher
rate of complications. The mechanisms of tachycardia were
similar in both groups, however atypical AVNRT occurred
more frequently in the older patients.
Discussion
Compared to the adult patients, several points differ in the
elderly population.
Table 1 Comparisons of clinical, EP and therapeutic
data between our study population versus patients
younger than 70 years of age.
Age <70
675
Age >69
141
Cardiac disease 11 (1.6%) 35 (25%) P<0.001
Syncope 11 (1.6%) 26 (18%) P<0.05
AVNRT 76 (16%) 101 (72%) NS
Latent Bundle of 
Kent
499 (74%) 11 (8%) NS
Atypical Tachycardia 59 (9%) 21 (15%) P<0.05
Ablation 26 (4%) 112 (79%) P<0.01
RF complications 383 (57%) 10 (7%) P<0.05
Induced AF 17 (2.5%) 27 (19%) P<0.01
RF: radiofrequency.
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The clinical signs were often more critical with syncope
in 26% of cases, cardiac decompensation in 7% of cases and
acute coronary syndromes in 10% of cases. This poor tole-
rance is probably explained by a higher rate of cardiac
comorbidities (25%) whereas typically, in a young patient,
PJTs occur on a healthy heart and are manifested by palpi-
tations with favorable prognosis [4]. A majority of patients
are seen between the ages of 50 and 60 [3], with frequently
a long history of initially well-tolerated tachycardia, tur-
ning to be less and less well tolerated with aging.
In the elderly, recurrence is more frequent [5], usually
with atypical clinical presentation, poor tolerance signs,
which can involve the vital prognosis [6]. The tachycardia
may lead to discomfort or syncope episodes, related to an
excessively high heart rate, in a patient with progressed
heart disease or presenting concomitantly carotid lesions,
or more often due to a vagal reaction [7].
Tachycardia can induce a coronary syndrome with episo-
des of angina, sometimes functional, in patients free of
significant coronary lesions. This can be at origin of fre-
quent hospital admissions in the emergency room or in car-
diology units for chest pain, since these older subjects are
at risk of atherosclerotic disease. Junctional tachycardia
can also destabilize an authentic, even severe, coronary
artery disease.
When relatively slow, this tachycardia can be undia-
gnosed. When prolonged, it may induce overt heart failure
as well as arrhythmic cardiac disease [8], which can be
totally regressive after the arrhythmia treatment.
Some unexplained strokes may be due to the transforma-
tion of PJT to atrial fibrillation [9]. The relationship between
these two entities is well known [10]; 12% of patients with
junctional tachycardia develop atrial fibrillation during the
first year [11], with an increasing risk with aging. The risk
of atrial flutter also exists [12]. These risks are not decreased
after PJT ablation [13]. We report 13% incidence of atrial
fibrillation (11% after ablation).
The PJT has exceptionally been associated to sudden
death [6, 8], if it occurs in the context of hypertrophic and
obstructive cardiomyopathy, it can be responsible for blood
pressure fall, which can lead to ventricular fibrillation. The
preventive treatment is therefore mandatory. Drug therapy
is often difficult to use since sino-atrial and AV conduction
troubles are frequent (28% in our series). In the elderly
patient, the choice of anti-arrhythmic drug is often limited,
and despite a close surveillance, side effects are more fre-
quent, due to comorbidities and drug interactions [14]. The
risk of drug over dosage is more frequent and a correct the-
rapeutic adherence requires adapted entourage, especially
in case of cognitive troubles. These patients have fre-
quently another cardiac disease or conduction abnormali-
ties affecting the sinus function or AV conduction, which
are susceptible to worsen with these anti-arrhythmic drugs.
In these conditions, RF ablation, routinely used since
several years [15-19], has been even more frequently used
in the elderly than in the younger patients in our center,
although the concerns for complications might have inter-
fered with our indications limited to poorly tolerated epi-
sode or drugs used. The NASPE registry included 1197
patients who had an ablation for AVNRT, with success rate
at 96.1% and 1% incidence of second- and third-degree AV
block. The recurrence rate varied from 2 to 10% during a
follow-up period ranging from a few days to several years.
In case of PJT ablation with a latent bundle of Kent, the pri-
mary success approached the 95% in most series, with a 5%
recurrence rate. In the 1995 NASPE registry, the incidence
of complete AV block varied from 0.17% to 1% and the rates
of tamponade varied from 0.13% to 1.1% after RF ablation
of an accessory pathway [20, 21].
The complications are now well described, whenever
they are simply related to catheterization as in our series or
to the ablation, with especially the risk of AV block in case
of ablation of the slow pathway [22] and tamponade, arte-
rial embolism or hematoma in case of ablation of a latent
bundle of Kent. In the elderly, these procedures are more
difficult, due to a small Koch triangle in case of ablation of
NRE tachycardia, or atherosclerotic lesions complicating
the arterial access for left bundles of Kent. Nevertheless,
the technical feasibility has already been demonstrated [2,
23], with even a larger quality of life improvement in the
elderly patients than in the younger ones [24, 25]. Howe-
ver, complications and recurrences are more frequent in
the elderly, and the junctional tachycardia ablation does
not seem to be protective of occurrence of atrial fibrilla-
tion [13].
Conclusion
In conclusion, junctional tachycardia should not be missed
in the elderly. They are not rare in the elderly and are often
presented by another complication. A cautious medical
treatment can be impeded by the presence of conduction
troubles or comorbidities. If this approach is not effica-
cious, these subjects might take benefit from curative abla-
tion. The complications are frequent but overall the suc-
cess rate remains high.
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